Jennifer K. Moses - Net Worth and Insider Trading
Jennifer K. Moses Net Worth
The estimated net worth of Jennifer K. Moses is at least $413,413 dollars as of 2024-09-20. Jennifer K. Moses is the CFO of G1 Therapeutics Inc and owns about 57,820 shares of G1 Therapeutics Inc (GTHX) stock worth over $413,413. Details can be seen in Jennifer K. Moses's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jennifer K. Moses has not made any transactions after 2023-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jennifer K. Moses
Jennifer K. Moses Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jennifer K. Moses owns 2 companies in total, including G1 Therapeutics Inc (GTHX) , and Viridian Therapeutics Inc (VRDN) .
Click here to see the complete history of Jennifer K. Moses’s form 4 insider trades.
Insider Ownership Summary of Jennifer K. Moses
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2023-01-05 | CFO |
| VRDN | Viridian Therapeutics Inc | 2021-07-14 | director |
Jennifer K. Moses Latest Holdings Summary
Jennifer K. Moses currently owns a total of 1 stock. Jennifer K. Moses owns 57,820 shares of G1 Therapeutics Inc (GTHX) as of January 5, 2023, with a value of $413,413.
Latest Holdings of Jennifer K. Moses
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2023-01-05 | 57,820 | 7.15 | 413,413 |
Holding Weightings of Jennifer K. Moses
Jennifer K. Moses Form 4 Trading Tracker
According to the SEC Form 4 filings, Jennifer K. Moses has made a total of 2 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in G1 Therapeutics Inc is the sale of 2,368 shares on January 5, 2023, which brought Jennifer K. Moses around $13,071.
Insider Trading History of Jennifer K. Moses
- 1
Jennifer K. Moses Trading Performance
Jennifer K. Moses Ownership Network
Jennifer K. Moses Owned Company Details
What does G1 Therapeutics Inc do?
Who are the key executives at G1 Therapeutics Inc?
Jennifer K. Moses is the CFO of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Financial Officer John V. Umstead , Chief Commercial Officer Andrew Perry , and Chief Business Officer Mark Avagliano .
G1 Therapeutics Inc (GTHX) Insider Trades Summary
Over the past 18 months, Jennifer K. Moses made no insider transaction in G1 Therapeutics Inc (GTHX). Other recent insider transactions involving G1 Therapeutics Inc (GTHX) include a net sale of 78,166 shares made by Rajesh Malik , a net sale of 92,308 shares made by Bailey John E. (jack) Jr. , and a net sale of 15,968 shares made by John V. Umstead .
In summary, during the past 3 months, insiders sold 17,114 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 17,114 shares. During the past 18 months, 295,121 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 295,121 shares.
G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.
G1 Therapeutics Inc Insider Transactions
Jennifer K. Moses Mailing Address
Above is the net worth, insider trading, and ownership report for Jennifer K. Moses. You might contact Jennifer K. Moses via mailing address: 79 Tw Alexander Drive, 4501 Research Commons, Suite 100, Research Triangle Park Nc 27709.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
